Williams R Sanders
- SEC CIK
- 0001375347
No open-market purchases or sales filed in the past year.
Current role at each company
- TNYA Tenaya Therapeutics, Inc.Directoras of May 29, 2026
- LH Labcorp Holdings Inc.Directoras of Feb 8, 2024
- AMGN Amgen IncDirectoras of May 23, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Williams R Sanders as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
AMGN Amgen Inc
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 22, 2022 (view filing) | Aug 22 | Same day | Williams R SandersDirector | SSale | −200 | $249.96 | −$50.0K | −3.6%5.30K after | |
| May 23, 2022 (view filing) | May 23 | Same day | Williams R SandersDirector | SSale | −600 | $250.00 | −$150.0K | −9.8%5.50K after |
LH Labcorp Holdings Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 29, 2022 (view filing) | Mar 25 | 4 days | Williams R SandersDirector | SSale | −572 | $272.98 | −$156.1K | −8.2%6.43K after |